Advertisement
Screener

Indivior Pharmaceuticals, Inc. (SUPN) Net Margin

Indivior Pharmaceuticals, Inc. (SUPN) Net Margin

  • 2026-06-30: Net Margin -26.65%.
  • 2026-03-31: Net Margin -1.10%.
  • 2025-12-31: Net Margin -1.94%.
  • 2025-09-30: Net Margin -23.49%.

Complete source-backed net margin history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-26.65%
2026-03-31-1.10%
2025-12-31-1.94%
2025-09-30-23.49%
2025-06-3013.60%
2025-03-31-7.89%
2024-12-318.80%
2024-09-3021.91%
2024-06-3011.83%
2024-03-310.09%
2023-12-310.72%
2023-09-30-10.38%
2023-06-30-0.61%
2023-03-3111.02%
2022-12-3115.23%
2022-09-300.99%
2022-06-304.63%
2022-03-3116.80%
2021-12-311.54%
2021-09-3014.52%
2021-06-3016.79%
2021-03-314.35%
2020-12-3121.43%
2020-09-3025.78%
2020-06-3027.36%
2020-03-3122.66%
2019-12-3132.98%
2019-09-3028.26%
2019-06-3031.26%
2019-03-3121.46%
2018-12-3122.33%
2018-09-3027.20%
2018-06-3030.88%
2018-03-3129.14%
2017-12-3115.82%
2017-09-3020.45%
2017-06-3023.69%
2017-03-3118.27%
2016-12-3123.44%
2016-09-30111.16%
2016-06-3020.37%
2016-03-3111.21%
2015-12-3116.08%
2015-09-3010.16%
2015-06-305.85%
2015-03-313.26%
2014-12-31-86.65%
2014-09-30124.08%
2014-06-3011.60%
2014-03-31-172.80%
2013-12-31-218.19%
2013-09-30-2132.39%
2013-06-30-17764.29%
2013-03-31-12526.53%
2012-12-31-1240.86%
2012-09-30-14815.38%
2012-06-30-14815.38%
2012-03-31-4460.10%
2011-12-31195178.57%
2011-09-30-88490.91%
2011-06-30-983.60%

Annual Net Margin

DateNet Margin
2025-12-31-5.36%
2024-12-3111.16%
2023-12-310.22%
2022-12-319.10%
2021-12-319.21%
2020-12-3124.39%
2019-12-3128.79%
2018-12-3127.14%
2017-12-3119.48%
2016-12-3143.42%
2015-12-319.72%
2014-12-31-12.20%
2013-12-31-798.76%
2012-12-31-3127.30%
2011-12-316701.74%
2010-12-31-36285.85%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38